RecruitingNCT04869007

The Impact of Cesarean Scar Defects on the Success of Assisted Human Reproduction

The Impact of Cesarean Scar Defects on the Success of Assisted Human Reproduction: The Prospective NICHE-ART Study


Sponsor

University Hospital, Angers

Enrollment

250 participants

Start Date

May 30, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The prevalence of Caesarean sections continues to increase around the world. In France, the proportion of Caesarean sections has doubled from 11% in 1981 to 20,2% in 2016, bringing with it an increase in the risk of obstetrical complications. Uterine defects, or Isthomcele, first defined by Morris in 1995 as a scarring abnormality with a dehiscence of the hysterotomy following a caesarean section. This purely iatrogenic pathology can cause inter-menstrual bleeding or pelvic pain. Several definitions of isthmosceles exist in scientific literature with variations according to the nature of the reference examination chosen and the measurements made. However, for the majority of authors, isthmoceles are characterized by a residual myometrial thickness of less than 3 millimetres in the sagittal plane. The prevalence of isthmoceles amoung patients with a unicicatricial uterus is about 61%. Currently, the main diagnostic technique for isthmoceles are 2D or 3D ultrasound and hysterosonography. Small, non-controlled studies have found that surgical treatment of the isthmocele is effective in reducing metrorrhagia. In these studies, the authors noted that patients with metrorrhagia were also more frequently affected by secondary infertility. A small number of non-comparative studies with a low level of evidence have looked into the efficacy of surgical treatment of isthmoceles on related symptoms: metrorraghia, pelvic pain and/or secondary infertility. Their results show an idiopathic secondary infertility rate in the presence of isthmoceles prior to surgical treatment of approximately 66%. Significantly higher pregnancy rates after treatment suggest that the surgical management of isthmoceles is worthwhile. However, these data suffer from not negligible selection bias. The initial findings concerning fertility after surgical repair seem promising and some teams propose systematic surgical management of the isthmocele before a technique of assisted reproduction (ART) although without any evidence in literature. Isthmocele surgery can result in uterine perforations, adhesions and intrauterine synechia known to be detrimental to future fertility. The efficacy of surgical management of surgey must therefore be demonstrated prior to any attempts at treatment. This will require large prospective studies based on a consensual definition of isthmocele. The diagnosis using Hysterosonography is currently considered as the "gold standard" examination. The main hypothesis of our study is that a significant isthmocele, defined by a residual myometrial thickness of less than 3mm, measured in the sagittal plane by hysterosonography, could alter the results of ART.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 43 Years

Plain Language Summary

Simplified for easier understanding

This clinical study is investigating "The Impact of Cesarean Scar Defects on the Success of Assisted Human Reproduction". Researchers are looking for volunteers to help improve understanding and treatments in this area. You may be eligible if: - You are between 18 Years and 43 Years - You are female - Patients with a history of at least one cesarean section (single or multi-scarred uterus). - Secondary infertility requiring ART techniques (FIV or FIV ICSI). - A Hysterosonography examination as part of the pre-ART assessment allowing for the detection of the presence of an isthmocele. - French speaking patients - Patient affiliated to or beneficiary of a social security scheme You may NOT be eligible if: - You do not meet any of the study's exclusion criteria Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEhysterosonography

Isthmocele mesured by hysterosonography before ART procedure


Locations(9)

UH Angers

Angers, France

University Hospital of Brest

Brest, France

Hospital Center Sud Francilien

Corbeil-Essonnes, France

Creteil University Hospital

Créteil, France

University Hospital of Nimes

Nîmes, France

Tenon Hospital Paris

Paris, France

La Sagesse Clinic

Rennes, France

University Hospital of Rennes

Rennes, France

University Hospital of Saint Etienne

Saint-Etienne, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04869007


Related Trials